
## Plasma proteome variation and its genetic determinants in children and adolescents

Discovery and replication cohorts

Impact of demographic and health factors on plasma proteome

Effect of SNPs on the plasma proteome

Decomposition of variance in plasma protein levels

Characterization of pQTL effect sizes

Integrating pQTLs with variant–trait associations

Highly replicated pQTLs in children and adults



## Proteomic landscape of epithelial ovarian cancer

A proteomic landscape of Chinese EOCs

Malignancy-associated proteins in EOC tissue and plasma samples

Proteomic features among five histological subtypes of Chinese EOC

Proteins potentially correlated with prognosis of advanced HGSOC

Characterizing prognostic plasma proteins of primary HGSOC patients

Protein classifiers for prognosis prediction

Divergent DNA Damage Response in HGSOC: Primary vs. Relapsed


## Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions

Deep coverage of serum proteomes through circulating EVs analysis

Establishing a workflow for proteomics of serum SEV and LEV-enriched fractions

Application of the workflow for proteomics of serum SEV and LEV enriched fraction to study OAPS

## Plasma proteome profiling reveals dynamic of cholesterol marker after dual blocker therapy

Cohort characteristics and research design

Plasma proteome revealed negative linkage between cholesterol metabolism and oncogenic signaling after DBT

Thyroid hormone related clinical indicators are significantly altered by DBT

Integrated analysis of proteome and radiology imaging reveals the potential of APOC3 as a biomarker in the DBT response

Integrated proteome-clinical features-based machine learning model provide an accurate measure for DBT



## Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction

Patients included in the study

Overall architecture of pediatric SARS-CoV-2 and MIS-C plasma proteome

Characterizing pathways of activation in patients with MIS-C and SARS-CoV-2 infection

MIS-C is characterized by a disproportionate response to interferon gamma

MIS-C patients have an MAS-like phenotype characterized by IFNγ and CXCL9 signaling

PLA2G2A is a candidate biomarker for MIS-C and is associated with a thrombotic microangiopathy phenotype

Clinical heterogeneity among MIS-C patients


## Proteomic profiling reveals diagnostic signatures and pathogenic insights in multisystem inflammatory syndrome in children

Plasma proteins in children with MIS-C compared to controls

Diagnostic classifier for MIS-C using machine learning

Validation of the 4-protein diagnostic signature


## Longitudinal serum proteome mapping reveals biomarkers for healthy ageing and related cardiometabolic diseases

Serum proteome profiling of longitudinal cohorts

Longitudinal trajectories of serum proteome during follow-up

Identifying ageing-related proteins using longitudinal data

Biological implications of ageing-related proteins

Associations of ageing-related proteins with diseases

Ageing-related proteins as cardiometabolic health indicators

Determinants of PHAS and 22 ageing-related proteins




## Rare variant associations with plasma protein levels in the UK Biobank

UKB Pharma Plasma Proteome cohort characteristics

Variant-level associations

Assessing epitope effects

Gene-level protein abundance associations

Pan-ancestry collapsing analysis

Protein–protein interactions

Insights into allelic series

Biomarker discovery

Clonal haematopoiesis pQTLs

pQTL-augmented PheWAS


### Large-scale plasma proteomics comparisons through genetics and disease associations
```
Comparison of precision
Inter-platform correlation of levels
Dilution and subcellular location
Protein–phenotype associations
Detection of pQTLs
pQTL analysis by ancestry group
pQTL comparison between platforms
Relationship of pQTLs between platforms
Pleiotropic pQTLs
pQTLs and disease-associated variants

```


### Plasma proteomic associations with genetics and health in the UK Biobank
https://metabolomips.org/ukbbpgwas/

```
Data processing and quality control
Proteomic links with health and disease
Discovery of pQTLs
Replication of pQTLs
Non-European pQTL mapping
Comparisons with previous pQTL studies
Identification and fine-mapping of independent signals
SNP-based heritability of proteins
Protein interactions and pathways at trans loci
Insights into cytokine interactions
Complement cascade trans pQTL networks
Scaling of pQTL associations
Co-localization with expression QTLs
Drug targets and disease biology applications

```


### Blood protein assessment of leading incident diseases and mortality in the UK Biobank
```
Protein associations with incident outcomes
ProteinScore development
Exploration of the type 2 diabetes ProteinScore
Metabolomic score comparison

```


### Systematic discovery of gene-environment interactions underlying the human plasma proteome in UK Biobank
```
Discovery of variance QTLs underlying the plasma proteome
Variance QTLs largely overlap with main effect QTLs for the blood proteome
Variance QTLs unveil gene-environment interactions dispersed across the plasma proteome
GEIs implicate known biological pathways and are influenced by age and sex
Gene-environment interactions capture why some vQTLs lack genetic main effects on protein levels
Alternative explanations for variance QTLs underlying the plasma proteome
```





## New biomarkers of Kawasaki disease identified by gingival crevicular fluid proteomics

Finally, MRM-MS confirmed the expression patterns of 12 DEPs (IFIT3, UB2L6, HP, A1AT, HSP90AA1, HNRPC, HSP90AB1, SAA1, MX1, B2M FKBP4, and TRAP1), thereby demonstrating high consistency with the DIA results and further validating the DEPs’ potential as biomarkers for KD.

